This compound is primarily utilized in the development of antiviral medications, particularly for targeting RNA viruses. Its modified structure allows it to interfere with viral replication by acting as a nucleotide analog, which gets incorporated into the viral RNA during synthesis, leading to chain termination or errors in replication. This mechanism makes it a promising candidate for treating viral infections such as hepatitis C or other RNA virus-related diseases. Additionally, it is studied for its potential use in cancer therapy, where it may inhibit the growth of cancer cells by disrupting their DNA or RNA synthesis processes. Research is ongoing to optimize its efficacy and reduce potential side effects.